PathogenDx Lands $7.5M in Series B Funding

Sep 30, 2019

|

NEW YORK – PathogenDx, which provides DNA-based pathogen testing for the cannabis, hemp, agriculture, and food safety industries, said today that it has raised $7.5 million in a Series B funding round.

The investment round was led by Cresco Capital Partners with participation from Altitude Investment Management, Arcadian Investment Partners, Panther Opportunity Fund, Salveo Capital, Flatiron Venture Partners, and other investors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Letting Samples Fly

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing.

Layoffs at 23andMe

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Dusty Resistance

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports.

Science Studies Use Single-Cell RNA Sequencing to Study Cell States, Apply Deep Phenotyping to Pregnancy

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.

Featured White Papers

A Machine-Learning Framework for Accurate Classification and Quantification of Oncogenic Variants Using the QuantideX NGS DNA Hotspot 21 Kit

BCR-ABL1 Minor Breakpoint (e1a2) Monitoring Using an Analytically Validated Multiplex Assay

Modifications to RNA Isolation Protocols Meet Requirements for Modern CML Monitoring of BCR-ABL1 Transcript Levels

Analytical Validation of the QuantideX NGS DNA Hotspot 21 Kit, A Diagnostic NGS System for the Detection of Actionable Mutations in FFPE Tumors

Jan

28

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb

05

Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Feb

25

Featured Webinar

Long-Read Sequencing of Human Transcription Provides Insights into Metastatic Cancer

This webinar will discuss a study that used long-read transcriptome sequencing to explore the distribution of isoforms in colon cancer samples and their metastasis counterparts.

Feb

26

Featured Webinar

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

Menu

PathogenDx Lands $7.5M in Series B Funding

To read the full story....

Breaking News

People in the News: Kumud Kalia, James McNally, Jay Flatley, More

Predictive Oncology to Acquire Quantitative Medicine

In Brief This Week: Bio-Techne, New York Genome Center, Oncimmune, and More

Federal Court Whittles Down Fluidigm Lawsuit Against IonPath

British Columbia Team to Study Campylobacter Omics With $500K in Genome BC, Genome Canada Funding

NIH to Establish Expert Panels for Curation of Disease-Linked Genes, Variants

The Scan

Letting Samples Fly

Layoffs at 23andMe

Dusty Resistance

Science Studies Use Single-Cell RNA Sequencing to Study Cell States, Apply Deep Phenotyping to Pregnancy

Featured White Papers

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Development of a Novel Multiplex Assay: A Partnership Case Study

Long-Read Sequencing of Human Transcription Provides Insights into Metastatic Cancer

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

What's Popular?

Diagnostics Developers Leap Into Action on Novel Coronavirus Tests

Ontera Developing Single-Pore Sensor for Sepsis, TB, and Zika Diagnostic Testing

Biocartis, AstraZeneca Expand Lung Cancer Biomarker Study With Master Collaboration Agreement

Co-Diagnostics Selling $5M of Shares

FNIH Team Selects Cancer Biomarkers in Phase I of Liquid Biopsy Reference Standards Project

Sponsorships